Before you sell to, join or invest in Endogenex, Inc.
MentionFox check on Endogenex, Inc.: only 1 source on file so far (checked 7 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/endogenex-inc-form-d-000004
Check Endogenex, Inc. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
Endogenex, Inc. filed an amended Form D with the Securities and Exchange Commission on 2026-11-06.
Endogenex, Inc. filed an amended Form D notice of an exempt securities offering with the SEC on November 6, 2026. The filing reports $132.35M sold. Its industry group is Other Health Care. It names Stacey Pugh (Executive Officer, Director), Juliet Bakker (Director), Gerald Brunk (Director) (SEC Form D/A, November 6, 2026).
125 companies raised this week.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| Andersen Aggregator LLC | $1.9B | Business services |
| AT Umbrella LLC | $1.9B | Business services |
| Legora, Inc. | $221M | AI and software |
| MD INVESTMENT LLC | $169M | Business services |
| Serval Inc. | $149M | AI and software |
Is this your company?
Sell to companies like Endogenex, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2026-11-06 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Endogenex, Inc.
Free to see. No signup.
More on the people and the money behind Endogenex, Inc., from the filings we hold.
Other Health Care raises by companies based in Minnesota, filed within 90 days of this one, largest first.
Get an email when Endogenex, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Endogenex, Inc. raises, hires or launches. No email unless you switch it on.
Watch Endogenex, Inc. →Get the full cited report on Endogenex, Inc.
What the filing shows about Endogenex, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Endogenex, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Endogenex, Inc.'s address as 13755 1st Ave North, #100, Plymouth, MN 55441.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for Endogenex, Inc. →
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Endogenex, Inc. is a registered filer with the SEC (CIK 1730881) and has filed since 2023-02-24. 4 filings are on record, the latest on 2026-11-06.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Endogenex, Inc.'s Form D of 2026-11-06 names Stacey Pugh, Juliet Bakker, Gerald Brunk and 4 more as its officers, directors or promoters.
Its new offerings report $97.10M sold across 3 offerings, as its own filings state.
A hollow marker is an amendment (Form D/A); a solid one is an original Form D. The larger marker is the filing this page is about.
Trailing twelve months. 863 filings in Other Health Care, totalled by week. The dot is this raise, $132.35M, on the same scale — one filing against the whole group's total, so it sits low by construction.
Stacey Pugh is named as Executive Officer and Director on the Form D that Endogenex, Inc. filed with the SEC on 6 November 2026, one of 7 people that filing names.
Juliet Bakker is named as Director on the Form D that Endogenex, Inc. filed with the SEC on 6 November 2026, one of 7 people that filing names.
Gerald Brunk is named as Director on the Form D that Endogenex, Inc. filed with the SEC on 6 November 2026, one of 7 people that filing names.
James Eadie is named as Director on the Form D that Endogenex, Inc. filed with the SEC on 6 November 2026, one of 7 people that filing names.
Doug Reed is named as Director on the Form D that Endogenex, Inc. filed with the SEC on 6 November 2026, one of 7 people that filing names.
Thomas Shehab is named as Director on the Form D that Endogenex, Inc. filed with the SEC on 6 November 2026, one of 7 people that filing names.
Krissy Wright is named as Executive Officer on the Form D that Endogenex, Inc. filed with the SEC on 6 November 2026, one of 7 people that filing names.
7 people named on the filing — 2 holding an executive role and 5 as directors only.
Named as of the 2026-11-06 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Endogenex, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Endogenex, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Endogenex, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Endogenex, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Endogenex, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Endogenex, Inc.. With no account yet, you sign up free and land on the result.
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/endogenex-inc-form-d-000004